Trigeminal Neuralgia Clinical Trial
Official title:
Comparative Study Between Radiofrequency and Balloon Compression of the Gasserian Ganglion in the Treatment of Idiopathic Trigeminal Neuralgia
Verified date | February 2020 |
Source | University of Sao Paulo |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Two percutaneous procedures used in the treatment of idiopathic trigeminal neuralgia are analysed. The effects on pain relief, alterations in cutaneous sensibility and olfactory and salivatory functions are analysed as well.
Status | Terminated |
Enrollment | 33 |
Est. completion date | August 30, 2019 |
Est. primary completion date | March 31, 2019 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - Idiopathic Trigeminal Neuralgia - Refractory/Intolerable medical treatment - Pain restricted to second or third trigeminal division Exclusion Criteria: - Secondary Trigeminal Neuralgia - Pain restricted to the first trigeminal division - Refuse to participate - Unable to comprehend the questionnaires |
Country | Name | City | State |
---|---|---|---|
Brazil | HCFMSUP | São Paulo | SP |
Lead Sponsor | Collaborator |
---|---|
University of Sao Paulo |
Brazil,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Pain relief using numeric rating scale | Worst pain in the last 24h scale in the Brief Pain Inventory | 6 months | |
Secondary | Changes in how the pain is perceived by the patient assessed by the Short-Form of the McGill Pain Questionnaire | Short-Form of the McGill Pain Questionnaire | 6 months | |
Secondary | Changes in neuropathic pain quality assessed by Douleur Neuropatique 4 | Douleur Neuropatique 4 | 6 months | |
Secondary | Evaluation of chronic pain and its influence in patients life assessed by Brief Pain Inventory | Brief Pain Inventory | 6 months | |
Secondary | Changes in types of symptoms of neuropathic pain assessed by Neuropathic Pain Symptom Inventory | Neuropathic Pain Symptom Inventory | 6 months | |
Secondary | Changes in quality of life assessed by World Health Organization Quality of Life - brief form | World Health Organization Quality of Life - brief form | 6 months | |
Secondary | Both patient and investigator impression in the treatment assessed by Global Clinical Impression | Global Clinical Impression | 6 months | |
Secondary | Evaluation of how pain affects patients perception assessed by Pain Catastrophizing Scale | Pain Catastrophizing Scale | 6 months | |
Secondary | Onset of changes in anxiety or depression assessed by Hospital Anxiety and Depression | Hospital Anxiety and Depression | 6 months | |
Secondary | Quantification of facial sensibility changes assessed by Quantitative Sensorial Testing | Quantitative Sensorial Testing | 6 months | |
Secondary | Changes in olfactory threshold assessed by isopropanol solution | Olfactory Threshold using isopropanol solution | 6 months | |
Secondary | Changes in gustatory threshold assessed using sweet, sour, salty and bitter solutions | Gustatory Threshold using sweet, sour, salty and bitter solutions | 6 months | |
Secondary | Changes in salivary flow assessed using cotton weights | Evaluation of salivary flow using cotton weights | 6 months | |
Secondary | Changes in olfactory discrimination assessed using Sniffin' Sticks | Using Sniffin' Sticks to evaluate olfactory discrimination | 6 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05152368 -
Safety of Cultured Allogeneic Adult Umbilical Cord Stem Cells for Trigeminal Neuralgia and Peripheral Neuropathy
|
Phase 1 | |
Recruiting |
NCT02801630 -
An Evaluation of the Effect of a Surface Acoustic Wave Patch Device on the Symptons of Trigeminal Neuralgia
|
N/A | |
Completed |
NCT02473016 -
Nasal Carbon Dioxide for the Symptomatic Treatment of Classical Trigeminal Neuralgia
|
Phase 2 | |
Recruiting |
NCT01364259 -
A Study of Amifostine for Prevention of Facial Numbness in Radiosurgery Treatment of Trigeminal Neuralgia
|
Phase 3 | |
Completed |
NCT01364272 -
Diffusion Tensor Imaging Magnetic Resonance Imaging (DTI MRI) as a Correlate to Pain Relief and Facial Numbness in Patients Following Stereotactic Radiosurgical Rhizotomy for Trigeminal Neuralgia
|
||
Completed |
NCT00603694 -
Hippocampal Radiation Exposure and Memory
|
N/A | |
Completed |
NCT00913107 -
Efficacy and Safety Study of Lamotrigine to Treat Trigeminal Neuralgia
|
Phase 2/Phase 3 | |
Recruiting |
NCT04996199 -
Comparision Efficacy of Carbamazepine & Oxcarbazepine in the Treatment of Trigeminal Neuralgia- a Randomised Clinical Trial
|
Phase 4 | |
Completed |
NCT06240494 -
Predictive Factors in Maxillary and Mandibular Nerve Radiofrequency Treatment for Trigeminal Neuralgia
|
||
Completed |
NCT05712993 -
Comparative Study Between Transcoronoid and Infrazygomatic Anterior Maneuvers
|
N/A | |
Completed |
NCT04371575 -
Symptomatic Trigeminal Neuralgia Attributed to Multiple Sclerosis - a Prospective Study in 60 Patients
|
||
Completed |
NCT03669744 -
Regional Anesthesia in Refractory Trigeminal Neuralgia: 21 Cases Reported to the Limoges University Hospital
|
||
Completed |
NCT05032573 -
Feasibility of Olive Oil for Reducing Facial Pain of Trigeminal Neuralgia
|
N/A | |
Recruiting |
NCT05615714 -
Paresthesia-free Peripheral Nerve Field Stimulation for Trigeminal Neuralgia (FreeST Trial)
|
Phase 1/Phase 2 | |
Recruiting |
NCT04054024 -
Efficacy and Tolerability of Erenumab in Patients With Trigeminal Neuralgia
|
Phase 2 | |
Not yet recruiting |
NCT05451251 -
Deep Brain Stimulation for Refractory Trigeminal Neuralgia With a Demyelinating Pontine Lesion
|
N/A | |
Withdrawn |
NCT04353505 -
Intra-arterial Sphenopalatine Ganglion Block for Patients With Refractory Headache
|
Phase 1 | |
Withdrawn |
NCT01932255 -
CSF Leak Following Microvascular Decompression: the Benefit of Routine Postoperative Lumbar Tap
|
N/A | |
Completed |
NCT05075707 -
Comparison Between Magnetic Field and Laser Therapy in Management of Trigeminal Neuralgia
|
N/A | |
Completed |
NCT06334796 -
Artificial Intelligence-powered Virtual Assistant for Emergency Triage in Neurology
|
Early Phase 1 |